New patent expiration for Mayne Pharma drug RHOFADE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for RHOFADE
Annual Drug Patent Expirations for RHOFADE

Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

RHOFADE drug price trends.

Drug patent litigation for RHOFADE.

This drug has twenty-one patent family members in thirteen countries.

The generic ingredient in RHOFADE is oxymetazoline hydrochloride. One supplier is listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top